Mandate

Vinge has advised Stendörren in connection with a bond issue of up to SEK 1,000 million

August 14, 2017

Vinge has advised Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with a bond issue of up to SEK 1,000 million senior unsecured floating rate bonds.

The bonds have a tenor of three years and a floating interest rate of three-months Stibor plus 4 per cent. ABG Sundal Collier AB and Swedbank have acted as financial advisors to Stendörren. Swedbank also acted as Issuing Agent.

The proceeds from the initial bond issue will primarily be used for refinancing of Stendörren’s outstanding SEK 750 million bonds, which will be made through a repurchase offer. The proceeds from the bond issue will also be used for acquisitions, investments and general corporate purposes. 

In accordance with the terms and conditions, the bonds are intended to be listed and admitted to trading on the corporate bond list at Nasdaq Stockholm shortly. As a result, the Company has prepared a prospectus which today has been approved by and registered with the Swedish Financial Supervisory Authority.

Vinges team consisted of Louise Brorsson Salomon, David Andersson, Sabina Börjesson, Josefine Larsson, André Isacson, Lionardo Ojeda and William Kåge

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025